CSI Market
Sign In | Register

Xeris Biopharma Holdings Inc (XERS) Annual Balance Sheets

Annual · GAAP · USD millions
Access XERS quarterly Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Xeris Biopharma Holdings Inc.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent111.04
Short-term Investments, Total0.00
Cash & Short-term Investments111.00
Accounts receivable51.05
Inventories68.67
Other Current Assets0.00
Prepaid Expense, Current AS9.55
Total Current Assets240.31
Equipment/Property/Plant Net4.95
Goodwill net22.86
Intangible Assets88.08
Other Assets, Noncurrent27.33
Operating Lease Right Of Use Asset22.11
Total Assets383.53
Liabilities
Accounts Payable, Current AC3.08
Accrued Liabilities, Current AC33.16
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current73.34
Business Combination, Contingent Consideration, Liability, Current BU0.00
Total Current Liabilities109.57
Long-term debt220.34
Total Long-term Debt220.34
Deferred Rent Credit, Noncurrent DE0.00
Other liabilities, Noncurrent8.40
Operating Lease Liability Current6.23
Accruedreturnsreserve18.97
Supply Agreements Liability Noncurrent-
Deferred Income Tax Liabilities Net-
Operating Lease Liability Noncurrent31.53
Total Liabilities369.84
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock685.00
Retained Earnings / Accumulated Deficit-671.31
Other Equity-0.03
Common Stockholder's Equity13.69
Total Stockholder's Equity13.69
Liabilities & Stockholder's Equity383.53
4 historic quarters locked

Sign in to unlock the full Xeris Biopharma Holdings Inc balance sheet history.

Sign In Create Free Account

About Xeris Biopharma Holdings Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001867096-26-000016

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License